Follow
It is currently Sun Aug 20, 2017 9:30 pm
Change font size

  • Advertisement

*New MMAR Regulations*

by papapuff » Wed Jul 26, 2017 12:53 pm

cbc.ca



Innisfail-area residents oppose pot processing plant

Residents in Red Deer County are concerned with odour and crime if the plant is approved

CBC News Posted: Jul 26, 2017

Some landowners in an area east of Innisfail, Alta., are worried about a proposal to build a medical marijuana processing plant nearby.

The proposed site is surrounded by farmland and in an environmentally significant area.

Roughly 50 landowners met privately to go over their concerns on Tuesday night. Among them was Suzanne Hawkes Cole, who believes this is not the right location for an industrial facility.

"We urge the county to adopt a policy of zoning marijuana facilities into commercial areas that are already set up for heavy truck traffic, that already have reliable water and electricity supplies and are adjacent to higher-capacity policing services," Cole said. ​

Geoffrey White, who lives less than a kilometre from the site of the proposed facility, says he's been around grow-ops before and he's worried about the potential odours and other problems if the medical marijuana operation gets approved.

"They stink, they just stink," White said. "We have got enough crime out here already without having … I don't know, people who like to smoke it, coming out and going through the fence and trying to get in there — because they are going to try."

The company behind the application, Agrafina, is holding an open house on Thursday night to try to alleviate some of the fears before making a presentation to council next week, a spokesperson said.

Red Deer County Mayor Jim Wood said council has a tough decision ahead.

"Medical marijuana is something that is quite new, and so I think it's important that we take a hard look at the impact to our communities, and we want to make sure we are very informed," Wood said.

Council could approve, defer or reject the application next week.​
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

Advertisement

by papapuff » Wed Jul 26, 2017 6:30 pm

thewave.ca



Organigram Supports Proposal To Sell Recreational Marijuana Through Crown Corporation

Posted on Wednesday, July 26, 2017

Moncton based medical marijuana producer Organigram is one of several groups included in consultations provincial government about legalization of recreational use.

Chief Commercial Officer Ray Gracewood says they support selling recreational marijuana through a subsidiary of a Crown Corporation like NB Liquor.

"There's a lot of expertise within that channel as it relates to supply chain management, logistics, category management, retail design, the list goes on and on," says Gracewood. "In terms of why that is going to allow the Province of New Brunswick to fast forward, and keep as proactive and bullish a schedule on this file, we believe that would be the best partnership for a Phase 1 rollout."

He adds that system will allow them to capitalize on the major markets in New Brunswick and "to supply those major markets with product, our recommendation is that, coupled with a direct mail model which would then be a sort of supplementary service to allow service to rural areas within New Brunswick."

Gracewood says with a little over 11 months to go, there is a lot of work yet to be done.
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Jul 28, 2017 10:43 am

Canada NewsWire (press release)



International Herbs Medical Marijuana Joins Cannabis Canada Association

OTTAWA, July 28, 2017 /CNW/ - Cannabis Canada Association is pleased to announce International Herbs Medical Marijuana as the association's newest member.

International Herbs Medical Marijuana of Delta, British Columbia has a Cultivation License to produce medical cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).

With the addition of International Herbs Medical Marijuana, Cannabis Canada continues to increase its position as the leading organization of companies that currently hold Health Canada licenses to cultivate and sell medical cannabis.

"Cannabis Canada is pleased to welcome International Herbs Medical Marijuana to the Association," said Colette Rivet, Cannabis Canada's Executive Director. "As Canada continues down the path towards cannabis legalization, it is highly important that Licensed Producers continue to speak with a united voice to represent their interests and share their ideas with all three levels of government across the country."

"As a licensed producer of medical cannabis, International Herbs Medical Marijuana felt it was very important for our company to be part of the leading industry association for the cannabis sector in Canada," said Kevin Coft, CEO of IHMML. "At this very crucial time for the future of the sector, having an association that can effectively represent the interests of our industry in Ottawa and with the provinces and territories will allow us to focus on establishing and growing our business."

About Cannabis Canada Association

Cannabis Canada is the leading organization of Canada's Licensed Producers of Medical Cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).

The Association's mission is to act as the national voice for our members in their promotion of industry standards; support the development, growth and integrity of the regulated cannabis industry; and serve as an important resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes.

Members of Cannabis Canada share a philosophy of both patient-centric care and improved public health, and are committed to product safety and quality, secure and reliable access and the promotion of the safe and healthful use of cannabis. Website: http://www.cann-can.ca

About International Herbs Medical Marijuana

International Herbs Medical Marijuana Ltd (IHMML) is focused on cannabis cultivation, research, and product development. With strengths in the start-up sector, pharmaceutical industry, distribution, and horticulture, IHMML aims to deliver medical cannabis at a competitive price.

Zenabis is a brand of IHMML.

SOURCE Cannabis Canada Association

For further information: Colette Rivet, Executive Director, Cannabis Canada Association, colette.rivet@cann-can.ca, 613-407-1080

RELATED LINKS
http://www.cmcia.ca
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Jul 28, 2017 10:51 am

Daily Commercial News




Construction partners execute concrete plans for medical marijuana


by PETER KENTER Jul 28, 2017

No one was as surprised as Warren Bravo and Steve LeBlanc when Health Canada approved their application to become a licensed producer of cannabis for medical purposes. As co-founders of Green Relief, the business partners have leveraged their experience in the construction industry to make the business a success.

Bravo, is president of the Hamilton office of Bravo Cement Contracting, a third-generation family-owned contracting company offering concrete flatwork at offices throughout southern Ontario. LeBlanc is vice-president of Unique Restoration, a contractor specializing in concrete work.

"We saw an opportunity and applied for a medical marijuana license with plans to incorporate aquaponics, using cultivation of fish as part of a virtuous environmental cycle. We thought all of the licenses to produce and sell would be granted to big pharma and big tobacco companies—anybody but a couple of ham-and-egger construction guys—but we received a letter of intent from Health Canada on Dec. 24, 2013. That was enough of a push for us to finalize the design of our underground bunker building."

The application process required the partners to provide detailed plans, not only for the construction of the facility and it security, but also the operation of the plant. Bravo and LeBlanc toured grow-ops across North America to research best practices among successful growers. The partners naturally gravitated to building a concrete structure on 50 acres of farm land in Flamboro, Ont. owned by Bravo. The decision to incorporate aquaponics was as much a business decision as an ecological one. The facility could not be zoned to operate on Bravo's farmland because cannabis is not yet approved as an agricultural crop — however, fish farming met those criteria.

The grow-op building is a 32,000-sq.-ft. concrete bunker built into a hillside. The area was excavated and the concrete building was constructed to grade, roofed and then covered with three feet of overburden. Three-quarters of the building is buried with the south face exposed.

"We've been in construction in the Hamilton area for a decade and we were committed to using local Hamilton contractors to do the construction work," says Bravo. Contributing companies include general contractor Harm Schilthuis and Sons, T. Lloyd Electric Ontario Ltd., Besseling Mechanical Inc., and a slate of local engineering firms.

Green Relief received its approval to begin selling marijuana to the medical market in April, following a rigorous inspection of the facilities and security clearances for company personnel.

Bravo says that the aquaponics component of the growth cycle is working well. The fish create waste water, which is enriched and used to fertilize marijuana plants. The marijuana plants thrive on the components fish don't like, purifying the water, which is returned to the fish tanks. A bonus for local food banks—Green Relief is already donating 400 tilapia to Second Harvest every five weeks. The company will also be experimenting with the production of freshwater prawn and koi.

"We're on the leading edge of sustainable agriculture," says Bravo. "We're the only marijuana producer in North America, and perhaps the world, incorporating aquaponics into our business. It's a completely controlled environment day in and day out. I can tell you three years in advance what the harvest day will be for a crop of cannabis plants."

Green Relief now employs 28 people and expansion of the facility is imminent as the company plans to break ground on a similar facility covering an additional 210,000 square feet.

"We're also starting design of a 1.5-million-square-foot facility in a neighbouring jurisdiction," says Bravo. "That will make us the largest organic grow-op in the world."

Bravo says the company will forego recreational marijuana and continue to focus on the medical marijuana market.

"We're committed to working on the scientific forefront of what this product can achieve medicinally," he says.

"It's a new industry and your plans are only limited by your imagination. As construction guys, Steve and I like to do things methodically, grab the bull by the horns and get things done."

Jul 28, 2017
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Aug 01, 2017 2:18 pm

EIN News (press release)



Maricann Group Inc. Announces Appointment of New Director

/EINPresswire.com/ -- TORONTO, ONTARIO--(Marketwired - Aug 1, 2017) - Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) ("Maricann" or the "Company") a low cost, greenhouse producer of medical cannabis with market leading technological, differentiation, is pleased to announce the appointment of Gerhard Müller as an independent member of the Company's Board of Directors, subject to regulatory approval.

Mr. Müller is a former audit partner of Ernst & Young's German practice, responsible partner for the Technology, Media & Entertainment sector at Ernst & Young for the Germany, Switzerland, Austria (GSA) region. A Certified Public Auditor and Tax consultant, Mr. Müller studied economics and English in Munich and Manchester (UK). At Ernst & Young, the majority of his clients were companies listed either in Europe or in the US. He left Ernst & Young in 2013 and has been working in his own practice since then. Since July 2017, Mr. Müller is also deputy chair of the Supervisory board of m4e AG, a German listed media company.

"We are pleased to welcome Gerhard to the Board of Directors of the Company. Gerhard's significant experience in international transactions, knowledge of reporting requirements, and business structuring will help to ensure the execution of our strategy and reliability of our reporting," stated Ben Ward, Chief Executive Officer of the Company.

About Maricann Group Inc.

Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Toronto with a facility in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under federal licence from the Government of Canada. Maricann, which has federal licences to cultivate, process and distribute cannabis, services a patient base with more than 8,000 total registered patients since inception. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a fully funded 217,000 sq. ft. (20,159 sq. m) build out, to support existing and future patient growth.

Maricann Milestones

April 2013, Maricann Inc. is founded in Langton, Ontario, a well-established agricultural region in southwestern Ontario

March 2014, Maricann Inc. obtains its Health Canada licence to cultivate plants

December 2014, Maricann Inc. obtains its Health Canada licence to sell dried cannabis

January 2015, first dried cannabis sale

September 2016, Maricann Inc. earns its Health Canada licence to sell cannabis extracts

October 2016, first sale of extracted cannabis

December 2016, Maricann Inc. raises $22.5 million in private capital

January 2017, commences sale of clones

February 2017, Maricann Inc. raises $10 million in private capital

April 20, 2017, Maricann Inc. changes name to Maricann Group Inc.

April 24, 2017, Maricann Group Inc.'s first day of trading on the CSE

April 28, 2017, announces Advisory Board of German subsidiary

May 4, 2017, Maricann Group Inc. secures $42,500,000 non-dilutive debt-free financing for further German expansion
May 24, 2017, breaks ground on expansion of cultivation facility in Langton, Ontario

June 12, 2017, Maricann Group Inc. listed on HMMJ ETF

June 16, 2017, Maricann Group Inc. added to the CSE Composite Index

Aug.1, 2017, Maricann Group Inc. announces signed letter of intent with McKesson Canada

Aug. 1, 2017, Maricann Group Inc. announces appointment of Gerhard Müller to Board of Directors

For more information about Maricann please visit our website at http://www.maricann.ca.

Forward Looking Information

Certain statements in this document contain forward-looking statements which can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "desires", "will", "should", "projects", "estimates", "contemplates", "anticipates", "intends", or any negative such as "does not believe" or other variations thereof or comparable terminology. No assurance can be given that potential future results or circumstances described in the forward-looking statements will be achieved or will occur. By their nature, these forward-looking statements, necessarily involve risks and uncertainties, including those discussed herein, that could cause actual results to significantly differ from those contemplated by these forward-looking statements. Such statements reflect the view of the Company with respect to future events, and are based on information currently available to the Company and on assumptions, which it considers reasonable. Management cautions readers that the assumptions relative to the future events, several of which are beyond Management's control, could prove to be incorrect, given that they are subject to certain risk and uncertainties, and that actual results may differ materially from those projected. Factors which could cause results or events to differ from current expectations include, among other things: fluctuations in operating results; the impact of general economic, industry and market conditions; the ability to recruit and retain qualified employees; fluctuations in cash flow; increased levels of outstanding debt and obligations under a capital lease; expectations regarding market demand for particular products and the dependence on new product development; the impact of market change; and the impact of price and product competition. Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. The reader is cautioned not to place undue reliance on forward-looking information.

Investor Relations:
Shawn Alexander
VP Investor Relations
salexander@maricann.ca
289-288-6284

Media:
Carrie Booze
North 6th Agency
212-334-9753 ext.142
maricann@n6a.com

Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
289-288-6274

European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Aug 01, 2017 3:58 pm

Brantford Expositor



Cannabis company has growth plans

Tuesday, August 1, 2017

A Brantford-based medical marijuana company is growing its business locally and beyond with the purchase of a modern new greenhouse in Beamsville.

NewStrike, which operates Up Cannabis Inc., has received permission from Health Canada to increase production at its Brantford facility.

“Prior to the amendment to the licence our Brantford plant could only produce 100 kg. of dried cannabis per year,” said Jennifer Maccarone, the company’s vice-president of regulatory and governmental affairs. “Now our production is only limited by the security level of our vault, which can store a maximum of 625 kg of dried cannabis at any one time.”

The local Up Cannabis facility is 14,200 square feet over two floors and is located in an industrial area. The company received its license from Health Canada to start producing medical marijuana at its Brantford facility in December and production started in January.

The license held by Up Cannabis has also been amended to allow the production of cannabis seeds and oils at the facility. Plans call for production to begin as soon as possible, Maccarone said.

“As soon as we get our equipment in, we’re ready to move into production, so in the very near term,” Maccarone said. “Our plan is to incorporate oil production into our current production stream, so we plan to continue producing dried cannabis in Brantford for the foreseeable future.”

The move to cannabis oil production will add a minimum of three full-time highly-skilled professionals to the operation whose focus will be on oil production. The addition of new staff will bring to 25 the number of people working at the Brantford facility.

The company has also announced its purchase of a 200,000-square-foot facility in Beamsville from Westbrook Greenhouses Ltd. for just over $7 million. The new facility will enable Up Cannabis to increase its annual production of cannabis.

“The Niagara acquisition is a huge step forward in the realization of the company’s growth strategy,” Jay Wilgar, CEO of Newstrike, the parent company of Up Cannabis, said in a statement. “It adds a potential five-fold increase in cultivation capacity and will introduce economies of scale into our operations.”

There will be approximately 100 full-time positions at the facility in addition to local job generation through construction, Wilgar said.

The Beamsville greenhouse sits on a 16.6-acre parcel of land with the potential of adding another 140,000-square-feet of production space. If the company is able to realize that potential, it would be capable of producing about 25,000 kg a year.

The company has also purchased a facility in Creemore, in Simcoe County, north of Toronto.

Newstrike, the parent company of Up Cannabis plans to develop a diverse network of cannabis brands that meets the needs of medical clients and eventually,

as the law allows, adult consumers. More information about the company can be found online at http://www.newstrike.ca.

In May, it was announced that iconic Canadian band The Tragically Hip has become a partner and investor with the company.

At that time, the band said it likes Newstrike because the company had “hired preeminent scientists and growers,
developed large, well-structured sites and have the wherewithal and expertise to take this on.”

As well, the band, noted in a statement, that medical cannabis is legal in Canada, and it already benefits the “health and well-being of many of our fellow Canadians.”

The federal government plans to make cannabis legal for recreational use on July 1, 2018.

Vball@postmedia.com
twitter.com/EXPVBall
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Aug 02, 2017 3:32 pm

CTV News



New medical marijuana facility to bring new jobs to Bracebridge

Heather Butts, Reporter/Videographer, CTV News Barrie
@HeatherButtsCTV

Published Wednesday, August 2, 2017 5:38PM EDT

A new medical marijuana facility is aiming to create about 100 new jobs in Bracebridge.

Muskoka Medical Marijuana Company is still two months away from being ready to produce prescription pot, but officials have big expectations.

"We anticipate doing about 2,000 kilograms annually on the first floor of the building and then we can expand to the second floor down the road," says Nick Anderson, vice president of operations.

Health Canada estimates, at the end of 2016, more than 130,000 Canadians were using medical marijuana.

CEO David Grand says licenced producers are struggling to keep up with the demand, so he's already preparing for an expansion.

"We've just announced that we've acquired behind me, another 40 acres, basically to put it in perspective you can put up to three Home Depots on that land."

While the province hasn't decided how it will regulate the production and sale of recreational pot, he's preparing for that too.

"I think obviously the Muskoka name, the fresh air, clean water and so forth that will obviously help us sell a lot of product, we hope."

The company plans to do its hiring over the next few months and they expect to have plants growing by the end of the year.
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Aug 04, 2017 1:26 pm

bnn.ca


August 4,2017

Premium cannabis lifestyle brand from the Napa of the North

Don Hauka, special to BNN.ca from Market One Media

DOJA Cannabis Company added to the portfolio of winery owner and SAXX founder Trent Kitsch
Trent Kitsch may be the only businessperson in Canada who owns both an award-winning winery and a cannabis production license.

So it’s hardly surprising when, asked to describe his marijuana product line, the DOJA Cannabis Company Limited CEO sounds somewhat like a seasoned sommelier.

“When I look at cannabis flowers, I do the same things people do with wine — I look at them for colour, trichomes (crystallization) and size. I press them to see how moist they are, and I appreciate the aroma and try to detect specific terpenes (scents), such as lemon, pine or chocolate, and finally, I savour the taste,” says Kitsch. “I think the ritual of wine and the ritual of cannabis are similar.”

Kitsch is bringing his experience in building the successful SAXX Underwear and Kitsch Wines brands to DOJA, one of only 52 federally licensed cannabis producers in Canada. And he’s going to do it by shattering the historic stereotype associated with cannabis consumers.

“I think that the perception of a typical cannabis consumer too often is that of a lazy person stuck to a couch that has the munchies all the time,” says Kitsch.

“That is just sad and it’s not accurate. I know so many of my peers and so many people in the industry who are very successful business people, great people and cannabis isn’t what defines their lifestyle — it’s just a part of their lifestyle.”

The DOJA lifestyle Kitsch and his team will promote is a positive, active one that’s in keeping with the Okanagan’s “Napa of the North” way of life that takes full advantage of the region’s world class wineries, lakes, orchards, golf courses and ski hills. And one he believes will also feature lucrative cannabis tourism industry that will one day overtake wine tourism.

“It’s a proud cannabis lifestyle that is active and stigma-killing,” says Kitsch. “It’s very similar to the authentic Okanagan winery lifestyle that’s here. I’m not going to say it’s luxury, but our cannabis is going to be premium, and I think the people who are living the DOJA life are living a premium life. We bridge that gap between medicinal and wellness, which we really feel is lifestyle.”

DOJA’s wholly owned subsidiary Northern Lights Marijuana Company received its license to cultivate under the Access to Cannabis for Medical Purposes Regulations in June, one of only 52 licenses in Canada held by 43 separate companies. That major milestone puts the company in good position as the launch date of July 1, 2018 for a legalized recreational cannabis use nears.

“It’s a 10-years-in-the-making overnight success story,” laughs Kitsch. “We’ve been at it since 2013 when we did our application and since that time, methodically, we have made milestones in the business, and I think timing-wise, we’re on pace to be selling our first batches in Q1 or Q2 of next year, which will be lining up perfectly for recreational cannabis.”

That’s a market that Deloitte estimates to be worth between $4.9 billion to $8.7 billion, based on demand of 655,000 kg/year. To tap it, Kitsch and his DOJA team are taking the same approach that made SAXX Underwear one of the fastest growing underwear brands in North America.

“I believe that people love the underdog story, and they like the individuals or brands that are in the subculture,” says Kitsch.

“People always like to think that they’re into something that’s new or the ‘new-new’. SAXX was successful in knowing how to reach people who were interested in being early-adopters to things — being innovators.”

To help establish the DOJA brand, and give consumers a taste of the lifestyle, Kitsch and company are opening a café in the heart of downtown Kelowna.

“The DOJA Cannabis Culture Café is on Bernard Street, which would be like Robson Street or Queen Street West,” he says. “We’re creating a place with a very open vibe, with coffee and food and special events — the things that we naturally do well in regards to Kitsch Wines or how we did with SAXX.”

Customers will learn more about cannabis, talk one-on-one with staff, and be able to meet doctors to find out the health benefits of different cannabis strains. They’ll also be able to purchase branded DOJA clothing and accessories.

“Fashion is part of our background, and we're going to have a fashion aspect to the brand, which is going to be sold at our cafes and online, and so far, people are really responding well to the events we’ve had, and some of the gear we see people wearing around town,” says Kitsch.

While cafes, clothing and the Napa North lifestyle work up front establishing the DOJA brand, the nuts and bolts of the operation have been quietly and methodically assembled in the background. And as with all his business ventures, Kitsch has every angle covered, from the business plan to the brand new growing facilities in West Kelowna.

“From all reports, when people visit our facility, we have one of the best facilities they’ve seen,” says Kitsch.

At their 7,100-square foot Phase I facility, DOJA will grow a range of curated handcrafted strains ideally suited for Canada’s emerging recreational market. The facility houses three grow rooms with a combined production capacity of 660 kilograms per year. Plans for a much larger Phase II facility are in the works.

Neal Gilmer, an investment analyst with Haywood Securities in Toronto who has followed the cannabis industry since 2014, says Kitsch is making all the right moves to make DOJA a success, and to differentiate the company from other pharma, medi and bio licenced producers by focusing on lifestyle.

“It is a bit of a unique approach, and I think it’s a good one,” says Gilmer.

“I think they've done very well with that they’ve accomplished to date. They’ve demonstrated that they can execute on what they say they’re going to go out and do so far.”

Gilmer says while the cannabis industry might at first appear confusing to investors, “it's no different than any other industry” in North America or elsewhere.

“You look at the management team,” he says. “You want to have a good management team in there, people who you trust when you shake their hand and have a good track record, and DOJA has a good track record.”

Kitsch said the company’s success to date is thanks to a strong team, most of whom he’s worked with in the past building SAXX and Kitsch Wines into winners.

“You can’t do anything without a great management team, and we really do have a great team. We all come from a background of working together at SAXX or playing sports together,” says Kitsch.

“We’ve got the most authentic, youngest, hungriest management team in the industry, who do things a little bit differently with a start-up mentality and a proven track record in building brands and building businesses.”

As DOJA prepares to go public this summer, not only does Kitsch have a great team, a unique marketing approach and one of the finest facilities, he has money in the bank.

“With $4.5 million in the treasury, we’re well capitalized. We have a company that has achieved value faster by completing our facility, getting our licence to produce, and hopefully in the future, getting our licence to sell sooner than many of our peers,” says Kitsch.

“I think we have a great story to tell.”

It’s a story that’s set to open a whole new chapter. On Wednesday, August 9, 2017 DOJA Cannabis Company Limited is scheduled to commence trading on the Canadian Securities Exchange under the four-letter symbol DOJA, so stay tuned for more news from the Napa of the North.
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Aug 08, 2017 10:46 am

Country Guide



Pot farmers needed

With a projected $22 billion in sales, Canada’s new cannabis market is generating a very heady kind of buzz in farm circles

By Shannon VanRaes
Reporter

Published: August 8, 2017

Working in total darkness, Thaddeus Conrad carefully feels his way up a nearly vertical set of stairs before switching on a single green light.

The bulb casts a weak, eerie glow, revealing a room packed with heavily budded marijuana plants.

But don’t jump to the wrong conclusion. There’s nothing clandestine about the hazy light. Pure and simple, this is great crop science at work.

“I like to keep them in total darkness the last three days,” Conrad says, speaking over the hum of numerous fans. “It brings out those trichomes.”

President and CEO of the Med-Man Brand, which he describes as a “weed-seed-feed” company, Conrad is philosophical when it comes to marijuana’s medicinal properties, but fastidious and technical when it comes to agronomic practices.

Inside a nondescript cluster of buildings south of Steinbach, about an hour southeast of Winnipeg, Conrad carefully measures nutrients, conserves moisture, monitors temperature and controls light at each stage of plant development.

His horticultural expertise has been hard won, and now, as Canada prepares for the legalization of recreational cannabis — the newly dignified term bestowed on pot, weed, Ganja and Mary-Jane — his skills are in high demand.

The federal government introduced the Cannabis Act in April, which stipulates that legalization occur sometime before July 1, 2018. With it comes a deluge of interest from investors and startups looking to cash in on a market estimated by some at more than $22 billion.

As of May 25, Health Canada had received 1,665 applications to become licensed producers of cannabis for medical purposes. Of those, 265 have been refused, 69 withdrawn and 858 deemed incomplete. Still, 45 licenses have been issued, and about 30 are actively producing cannabis.

Partly, the low approval rate is because, although many people have brought cash and business acumen to the table, few have stepped forward with the agricultural expertise needed to consistently produce high-quality cannabis.

“I think the biggest thing is that we have seen some people become licensed producers that don’t have the agronomic background to grow on a commercial level,” says Dan Clarke, executive vice-president of business development and agronomy at A&L Canada Laboratories. “They had to learn really quickly, and they made expensive mistakes… the agronomy always has to come first or you are just not going to have a quality product.”

Clarke grew up on a cow-calf operation in Ontario before studying agronomy, first working with medical opium in Australia before moving on to medical cannabis, a plant he says has been underestimated in terms of production challenges.

“Some of these licensed producers, some of the initial ones, came into it and thought, well, marijuana is a weed, you can grow it anywhere,” he says. “And that statement is true, but we’re trying to grow a high-yielding, high-quality, safe product and there are certainly agronomic things that need to be looked after.”

Primarily, says Clarke, “Medical cannabis is no different than growing canola or cherries or corn or alfalfa. At certain growth stages it has certain requirements for nutrition and we have to make sure we are meeting those requirements.”

Back in southern Manitoba, Conrad blames police forces for spreading the idea that potent cannabis can be easily produced by lazy and itinerant criminals.

“The establishment has tried its best to shame marijuana users and marijuana producers, and a part of that shame is convincing the general public… that you plant seeds and you go on vacation to Jamaica for three months and then you come back and you collect a million dollars,” says Conrad, who is permitted to produce medical marijuana for himself and three others.

“What police and RCMP have always told me is, ‘You’re taking the easiest way out’ and you know what the biggest irony of those ignorant statements is? It’s that I have lived the hardest life of anyone I know… I’ve endured beatings from police, I’ve endured jail, I’ve endured petty court cases.”

Reaching into a warmly lit growth room to turn down speakers playing classical music, Conrad adds that in some cases there is also a reluctance on the part of licensed producers to hire growers who honed their skills in the black market.

“These corporate bigwigs aren’t hiring the right people,” he says. “They don’t want experienced people.”

Already, production issues have led to marijuana recalls in Canada. Random testing by Health Canada at Hydropothecary Corp’s facility in Gatineau, Que., this spring found leaf samples that tested positive for myclobutanil, a mildew-killing agent that becomes hydrogen cyanide when exposed to heat.

Other licensed producers have issued similar recalls in recent months, including Aurora Cannabis, Organigram Inc. and Mettrum Ltd.

“You can see that as an industry we are very young and infantile,” says Cole Cacciavillani, co-founder of Ontario-based Aphria.

The industry, he says, has been sending out messages that legally produced cannabis is healthy, and much better quality than what you can buy on the street. “We haven’t been able to make that claim without getting ourselves into trouble,” complains Cacciavillani. “We have to get there, we have to be able to tell consumers we are there.”

With 30 years of experience in the greenhouse industry, Cacciavillani says Aphria is probably the “only truly agricultural player” in North American cannabis. So it’s no surprise that Cacciavillani is critical of the federal government’s decision to leave Agriculture and Agri-Food Canada on the sidelines as legalization approaches.

Leaving the regulation of crop production entirely in the hands of Health Canada, he says, has contributed to more hurdles for marijuana producers.

“In all fairness to Health Canada, I don’t think they realized the whole scope and dynamics, and the geography, and how this whole thing really works,” Cacciavillani says. “When you actually start to get down here and you manage it, and you really have to start to ramp up production, that is where some of these issues are.”

Luc Duchesne, the chief science officer at WeedMD Rx disagrees on that point, at least in part. While he accepts that Health Canada has a steep learning curve ahead, the biochemist says the agency is a better choice for the regulatory tasks ahead than other government agencies.

“There is a need to educate the regulator about the biology of the plant, but it’s not a deficit… we can all collectively get a better understanding of the biology of this crazy creature that is cannabis,” says Duchesne. “Growing cannabis is really hard, it’s complicated.”

Cannabis, he says, “is a living organism that has all kinds of peculiarities that makes things very, very complicated for anyone trying to do it.”

Supreme Pharmaceuticals, which operates a federally licensed cannabis production subsidiary called 7ACRES in Kincardine, Ont., hired Conrad to get its production system up and running.

“It is an honour to have him,” Supreme’s executive vice-president Brayden Sutton told the Financial Press at the time. “He brings with him decades of practical experience, as well as a large and loyal patient following.”

Other Canadian cannabis companies have similarly turned to private consultants in an attempt to manage production issues and build agricultural expertise. Meanwhile, however, conventional farmers have remained on the sidelines as the country moves towards legalization.

“There are some other agricultural guys now looking at this space and trying to decide to get in, but capital becomes an issue,” says Cacciavillani.

Clarke agrees that capital costs are a barrier for conventional grain or livestock producers interested in diversifying with cannabis, but notes that stringent regulation is also a drawback — not to mention costs associated with security. Still, he says some farmers are tire-kicking the idea, particularly if they have surplus buildings or are in an industry with transferable infrastructure, such as greenhouse production.

“The other thing is, and this has nothing to do with crop production or anything, but some people just have a moral issue with it and that becomes a bit of a challenge as well,” Clarke adds.

Others think the technical aspects of cannabis production could be why conventional farmers are steering clear of the emerging crop.

“This is still very specialized agriculture. And part of the problem, what makes it so specialized, is the regulatory framework that you’re bound to carry with you,” Cacciavillani says.

“Even I found it quite overwhelming,” he says. “We brought in people from the pharmaceutical world to deal with the regulatory side of it.”

Concerns about monoculture have been raised by the cannabis community as large players prepare for legalization, but Conrad and others believe once the groundwork is laid, craft and specialty growers will find a home in the market. These niche markets could be more enticing to farmers looking to diversify as well, says Clarke.

Still, many questions remain about how legalization will work. While the expectation is that the medical cannabis producers of today will be the recreational producers of tomorrow, exactly how that transition will occur is yet to be determined.

What is clear, though, is that today’s legal growers won’t be able to meet consumer demand.

“One of things we’ve learned collectively as licensed producers is that each facility has its quirks, and to be able to produce the best quality cannabis at high yields, it takes a little bit of time to get there,” says Cam Battley of Aurora, which operates a production facility roughly the size of 16 football fields at Edmonton’s international airport.

At full capacity, Aurora will be able to produce 100,000 kilograms of marijuana each year — just a fraction of the 800,000 kilograms of the annual demand Battley anticipates following legalization.

“The volumes that we’re going to need to supply… they are incredible and we cannot grow those volumes in isolation wearing loud shirts and playing loud music. That’s not going to cut it,” says Cacciavillani.

Still, Cacciavillani sees smaller players entering the market in the coming years.

One of the big questions, however, is how many small-scale producers will be allowed to go after a slice of the action.

Battley speculates Health Canada will limit the number of growers at some point. “I would imagine that they are looking for a system that they are capable of regulating, and to me that means, not thousands of producers, but a manageable number,” he says.

For its part, Health Canada declined to be interviewed for this story.

As if existing production challenges weren’t heady enough, Cacciavillani sees fresh challenges on the horizon. For decades, cannabis strains or varieties have been bred for increased levels of tetrahydrocannabinol — better know as THC — or for specific cannabinoids like cannabidiol. Black market breeders have not necessarily focused on developing disease resistance, although even if they had it might be moot. Legally obtaining genetic material takes businesses down a winding, shifting path with limited choice.

Initially only one strain of cannabis was on offer from the Canadian government —developed from seeds seized by law enforcement, according to many in the industry.

Today, many cannabis strains have worked their way into the medical market one way or another, giving licensed producers new options. Still, there is concern about the process of legitimizing black market genetics.

Cacciavillani suggests another solution to the problem, one so far removed from the philosophy of many growers and consumers it drew an audible gasp from the crowd when he mentions it at a Cannabis Canada forum held in downtown Winnipeg earlier this year.

“The Monsantos of the world, the Syngentas of the world need to be involved,” Cacciavillani says, adding biotechnology is the only route to managing pests and disease without relying solely on pesticides. It’s a contentious issue, with some at the forum immediately voicing their opposition to what was dubbed “Roundup ready cannabis” by attendees.

“We’re going to have stuff hit us,” Cacciavillani responds. “One of the problems we’re going to have is that these places are continually producing and we’re going to start to introduce disease, and then we’re going to start to have mutations of diseases that we haven’t even seen yet, and we’re going to need help when that happens.”

Stepping out of his grow rooms, past some small Health Canada signs and into the soft afternoon light of summer, Conrad says he respects all the work and business skills cannabis startups have brought with them, but stresses that producing marijuana takes more than investment dollars.

“Where they fall short is they don’t have the farmer mentality. They have a corporate, capitalistic mentality,” he says. “If you talk to any farmer… you will actually notice how different their mentalities are.”

In some ways, Conrad doesn’t see himself as a grower at all, but rather as an environmental balancer. “The plants are doing the growing,” he says, adding that in time the cannabis market will also find balances of production versus quality, large-scale versus niche, and medical versus recreational.

And amid all the questions, Conrad hopes Canadians take a moment to step back and look at the big picture.

“People need to realize that the prohibition of cannabis had nothing to do with the plant and everything to do with infringing on our human rights. It’s not a plant or substance issue but a human rights and human freedoms issue,” he says, adding, “Anything that is good for human rights is good for our economy and it’s good for jobs and it’s good for everything.”
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Wed Aug 09, 2017 10:21 am

Innisfail Province



No decision made on medicinal marijuana facility

Tuesday, Aug 08, 2017 04:30 pm
By: Lea Smaldon

RED DEER COUNTY - No decision has been made on whether the county will allow a proposed medicinal marijuana production facility on land about 30 kilometres east of Innisfail.

The county’s Municipal Planning Commision was to consider Agrafina Corp.’s application for a discretionary use development permit for a value added agricultural industry at its Aug. 1 meeting.

“The applicant withdrew the application from the agenda,” said David Dittrick, the county’s director of planning and development.

Agrafina is proposing to build and operate a 52,844-square-foot medicinal marijuana production facility on Rge. Rd. 254, just south of Highway 590.

The Calgary-based, family-run company made an application to Health Canada in March to become a licensed producer. It has not received approval as of yet.

The company states production would be for pharmaceutical purposes only. Growing marijuana for recreational purposes continues to be illegal.

Opposition to the land use mounted the week previous with area residents raising concerns at a meeting held in Pine Lake.

Odour, security and traffic concerns were noted.

Some suggested the facility would be better suited to an industrial area.

Dittrick said the application is not necessarily dead in the water.

“What (admnistration is) doing now is looking at zoning and regulations. We’ve been treating these as value-added agriculture,” said Dittrick. “Council thought maybe it wasn’t value added agriculture but maybe industrial.”

Currently, there is no special zoning or requirements specifically for medicinal marijuana production facilities under the county’s land use bylaw.

Agrafina’s application had to be approved by the county’s Municipal Planning Commision because the size of the proposed facility is larger than permitted.

At 52,844 square feet, the proposed facility would have been eight times the permissable square footage under the bylaw.

As such, the application was for a discretionary use.

Administration’s recommendation to the commision was to approve the application with conditions.

In a submission to the commission, Agrafina’s Rosina Smith said the county’s planning department was open to a medicinal marijuana project but wanted to ensure it was not in close proximity to residential developments.

“Our intent has always been to be open and transparent and to work collaborately with the county and the community in finding mutually beneficial outcomes. I am confident that once the operation is up and running that all questions, issues and challenges will all be allayed and that this development will provide economic value to the county. It is our greatest hope that it will serve as an industry benchmark for future medicinal marijuana operations,” Smith wrote in her submission.

Currently, there are three companies licensed to cultivate medicinal marijuana in Alberta: Acreage Pharms Ltd. near Peers, Airdrie’s Sundial Growers which is building a plant in Olds, and Aurora near Cremona in Mountain View County that is already producing.

Aurora is also licensed to sell and as of June 29, has surpassed 16,000 active registered patients less than 18 months after the company's first product sale in January 2016.

Aurora’s plant in Mountain View County is of similar size to Agrafina’s proposed facility, only a few thousand square feet larger.

The company is now listed on the Toronto Stock Exchange and is expanding operations with a new plant near the Edmonton airport.

Residents in the area where Agrafina’s proposed facility would be, say its location is not the right fit for the area.

Donna Gillrie told the Municipal Planning Commision in her submission that this type of facility should be in an industrial subdivision.

“I would ask you (because you all live in the county) would you like this to be in your community? We have so many people breaking in to farmyards already and this facility will only make it worse. I know you will say it will not, but criminals will come and try to get into something like this and when they can’t, they will stop at the next farmyard and take whatever they want from there,” Gillrie noted in her submission.

She raised concerns as well about how much water the facility would use.

Mike Grimberg lives on a farm directly north of the proposed facility and is also opposed to Agrafina locating there.

The federal corrections officer lists increased crime and traffic, road safety and environmental concerns like the venting of airborne THC, the active ingredient in marijuana, as concerns.

“The most pressing issue however is moral. Marijuana is a debilitating drug that harms society. Hall’s 2014 20-year meta-analysis for the World Health Organisation clearly states marijuana causes accidents, addiction, learning disabilities, lung disease, depression, cancer, impairs childhood brain development, affects non-users via second hand smoke and is implicated in schizophrenia in long-term users,” Grimberg wrote in his submission.

He concluded that residents are prepared to seek an injunction via the courts or Alberta Environment, or sue the county, should the county “ignore residents’ concerns and award licence to these ‘entrepreneurs’.”
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Fri Aug 11, 2017 11:12 am

Delta-Optimist



Pot could be replacing peppers

Village Farms has formed joint venture to cultivate and distribute cannabis for medical purposes

SANDOR GYARMATI / DELTA OPTIMIST

AUGUST 11, 2017

A new harvest tapping into a multi-billion dollar market could be taking root in Delta.

Greenhouse operator Village Farms International recently announced it formed a joint venture with Emerald ealth Therapeutics, a .C.-based licensed proucer of medical cannabis, o cultivate and distribute wholesale cannabis and annabis extracts for medcal purposes.

Also, if permitted by aw, the operation plans to row pot for "non-theraeutic" purposes.

Built in the mid-1990s nd now covering over 00 acres, the large-scale reenhouse operation at he corner of Highway 10 nd 80th Street is part of company that's among he largest growers and istributors of greenhouse roduce in North America, aving six greenhouses and four produce-distribution centres in B.C. and Texas.

Now peppers could be replaced with pot at the Delta operation if approvals to start growing medical marijuana is granted by the federal government. What's more, the feds are working toward legalizing recreational marijuana and are expected to have legislation in place by the summer of 2018.

A report by Torontolisted financial services group Canaccord Genuity Group last fall predicted the combined annual demand for recreational and medical marijuana would reach 575,000 kilograms by 2021. That leaves Village Farms with its huge greenhouse facility well positioned to take advantage of that massive, lucrative market.

In an interview following the announcement, Village Farms CEO Michael DeGiglio, noting there's no doubting the medical benefits of therapeutic marijuana, told the Delta Optimist they don't forsee any problems as far as growing the product. His company's expertise on growing crops, reputation and having a readymade facility will go a long way, he said.

"The huge investment is for security of the facility. The fencing, security camera systems, all that, is a huge investment and that would be where the biggest changes are, but nobody would notice that other than a secure fence around the facility," said DeGiglio.

He added, "We've looked at this market for years and initially we saw who entered the market upon the government deciding cannabis can be grown medically. There's been a turn from those original entrants to the market to more finance lawyers and promoters. We said it was only a matter of time until what we deemed as real companies with real track records, with a history of 30 years like us, publically traded, and are at a whole different level of professionalism, will come in."

Village Farms plans to initially allocate 25 acres of its Delta greenhouse for cannabis production. The joint venture also outlines an option to lease or purchase an additional 85 acres.

The initial 1.1 million square feet of greenhouse cannabis production is estimated to yield more than 75,000 kilograms of product annually. Village Farms notes the joint venture has the potential to have up to 4.8 million square feet of greenhouse production, estimated to yield more than 300,000 kilograms of product annually, which the company says would supply a considerable portion of the expected future cannabis demand in Canada or for export abroad.

Village Farms would be the first legal pot operation on Delta farmland, something the municipality had tried to restrict to industrial zones but was turned down by the provincial government.

Delta already has a medical marijuana operation, Zenabis West, setting up shop in an industrial property at Annacis Island. Health Canada granted the company, operated by International Herbs Medical Marijuana Ltd., a licence to produce medical cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations at the 25,000 square foot facility.
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Mon Aug 14, 2017 11:02 am

Truro Daily News



Nova Scotia’s first medical marijuana facility on target in Truro

Harry Sullivan harry.sullivan@trurodaily.com
Published on August 14, 2017

TRURO, N.S. - Construction on Nova Scotia’s first licensed medical marijuana production facility is expected to begin this month in the Truro Business Park.

Advertisement
“We’re ready to pour concrete up there now for the footings, the frost wall and the foundation,” said Evan Price, president of The Truro Herbal Co. (THC). “We’re ready and we can’t wait to get started.”

A contract has been awarded to Lindsay’s Construction of Dartmouth for development of a modern 20,000-sq.-ft., cannabis production facility.

Construction is expected to be complete by early 2018 and Price said he anticipates the first crop of medical marijuana will be available between February and March.

Following completion, a routine inspection by Health Canada is the final step in to the facility becoming the first licensed producer of medical marijuana in the province.

The project has already passed through various stages of approval and Price said he is confident of the “routine” aspect of he inspection, because after sending in 22,000 pages of detailed information on the facility to Health Canada, the agency only came back with four questions related to construction materials and security cameras.

The THC has also added to its current round of capital financing, Price said, raising to date $4.7 million in new cash and commitments since last December, including from prominent Nova Scotian entrepreneurs.

“These partnerships demonstrate confidence from the business community in our management team and market strategy as we head towards the legalization of recreational cannabis in 2018,” he said.

The overall project is expected to cost close to $10 million to get it to the operational stage. The first 15 investors in the project are primarily from within Truro.

“We’re continuing to look at partnerships,” he added.

hsullivan@trurodaily.com
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Aug 15, 2017 10:29 am

InvestorIdeas.com (press release)



Hydropothecary (TSX VENTURE: $THCX.V) Announces Release Of Honeydew, One Of Canada's Highest Legal CBD:THC Ratio Products To Date

GATINEAU, QC - August 15, 2017 (Investorideas.com Newswire) The Hydropothecary Corporation (TSX VENTURE: THCX) (the "Company" or "Hydropothecary") is pleased to announce it has started shipping Honeydew, the Company's highest CBD:THC ratio product offering to date.

Part of the Company's mid-market H2 product line, the dried bud has a ratio of 18.5 percent CBD to 1.8 percent THC, making it one of the highest CBD products available under Health Canada's regulations.

Honeydew complements the Company's existing CBD offerings, and brings the Company's total number of CBD products to five, including the recently released Passion Fruit. Passion Fruit is an indica-dominant hybrid cannabis strain that offers a 1:2 ratio of 5.1 percent THC to 10.7 percent CBD. Rounding out the CBD offering is Midday, Decarb 1:1 and Decarb High CBD.

"Together with our other H2 products, including Passion Fruit, Papaya Grove, Dragon Fruit, Bitter Melon and Juniper Berry, Honeydew has been developed to meet the needs of our clients at affordable prices, starting at just $7.25/g. Every new product we roll out has been carefully developed in response to what health care professionals need to help their patients," says Sebastien St-Louis, CEO and co-founder.

Honeydew and Passion Fruit are both available for $10/g under the H2 product line. For more information, please visit http://www.thehydropothecary.com/products/h2.

About The Hydropothecary Corporation

Hydropothecary is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides naturally grown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary's branding, cannabis product offering, patient service standards and product pricing are consistent with Hydropothecary's positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Jennifer Smith
Manager of Financial Reporting and Investor Relations
invest@thcx.com
1-866-438-THCX (8429)
http://www.THCX.com
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Tue Aug 15, 2017 3:17 pm

Red Deer Advocate



Red Deer County moves to simplify regulations to start medical marijuana grow-ops

MURRAY CRAWFORD Tue Aug 15th, 2017

Redefined bylaws could reduce some of the burdens to opening up a medical marijuana grow operation in Red Deer County.

Council gave first reading to amending the land use bylaw that would make it easier for the county to approve development permits for medical marijuana production facilities on Tuesday.

A public hearing on the proposed changes is slated for Sept. 19.

Grow operations would be permitted in business service industrial and medium industrial districts under the proposed bylaw amendments.

The changes would also eliminate some of the permit requirements from the county including developing a security plan, a ventilation plan, and Health Canada approval. These are already required by the federal government before granting a production licence.

Operators would have to ensure there are loading facilities, garbage and waste containers fully enclosed within the building; a fence, a drainage plan and confirmation a federal licence application.

The federal licence and the development permit are dependent upon each other for approval of a medical marijuana production facility.

Coun. Philip Massier raised a concern about an active application for this type of grow operation near Pine Lake. The development application is still active, but was withdrawn from the municipal planning commission’s agenda on Aug. 1

Should the applicant want to put tis application forward again, it would be subject to the new regulations if they were approved.

Most councillors said they were particularly interested in the outcome of the public hearing.

mcrawford@reddeeradvocate.com
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

by papapuff » Thu Aug 17, 2017 11:35 am

satPRnews (press release)



AUGUST 17, 2017 BY MONIKA DONIMIRSKA

Tilray Announces Second Facility Enabling 5x Increase in Production Capacity to Meet Rapidly Growing Global Demand for High-Quality Medical Cannabis

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray Canada Ltd., a Good Manufacturing Practice (GMP)-certified global leader in medical cannabis research and production, announced today that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will position Tilray to respond to significant projected growth in demand for its medical cannabis products in Canada as well as the European Union, Australia, New Zealand and Latin America.

“This is another strategic milestone for Tilray as we aim to build the world’s most trusted and admired medical cannabis brand,” said Brendan Kennedy, Chief Executive Officer of Tilray. “As governments around the world increase access to medical cannabis, and as Canada prepares to legalize and regulate cannabis for responsible adult consumption, this investment will enable us to serve the rapidly expanding global market for quality-controlled, rigorously tested medical cannabis products.”

Expanded Capacity to Accelerate Tilray’s Global Expansion Plans

Tilray was the first licensed producer to legally export medical cannabis products from North America to the European Union, Australia, New Zealand and South America. Currently, Tilray products – including pharmaceutical-grade whole flower, oils, and capsules – are available in 6 countries spanning 4 continents. The company is aggressively expanding international distribution of its products with plans to export to 5 additional countries by the end of 2017.

In 2016, Tilray also became the first medical cannabis licensed producer in North America to be GMP-certified in accordance with the European Medicines Agency’s (EMA) Good Manufacturing Practice (GMP) standards. GMP certification is the most rigorous standard that manufacturers of medical products must meet in their production processes, and it provides regulators and health care providers in countries new to medical cannabis with certainty that Tilray products are a safe and smart choice.

Tilray’s Best-in-Class Production Facilities

Tilray currently owns and operates one of the world’s most sophisticated, federally-licensed medical cannabis cultivation and processing facilities, located in Nanaimo, British Columbia. The flagship $30 million facility, which opened in 2014 and achieved EU GMP certification in 2016, has the capacity to produce 8 metric tonnes of medical cannabis per year. It also houses a state-of-the-art extraction and R&D centre focused on processing raw flower into pharmaceutical-grade products like oils and capsules, in addition to developing new methods of delivery that provide alternatives to smoking.

The company’s second facility being announced today is located in Enniskillen, Ontario on a 100-acre property with 13 acres of existing greenhouse space. The property is currently producing peppers for the Enniskillen Pepper Company. Tilray has submitted an application to Health Canada to receive a federal license to produce medical cannabis on the Enniskillen site. In the first phase of the project, the property will house a 10-acre cannabis greenhouse facility and approximately 40,000 square feet of processing space. The facility marks a total capital investment of up to $30 million and, together with Tilray’s Nanaimo facility, is expected to generate a combined production capacity of as much as 51 metric tonnes by the end of 2018. In future phases to be completed over the next several years, the first 10 acres of Tilray’s new greenhouse in Enniskillen will be expanded up to 30 acres.

Tilray chose Enniskillen because the township is strategically located and has a strong workforce of qualified, skilled agricultural professionals. The Enniskillen facility is expected to hire approximately 50 people to work in operations, production, cultivation and facilities through the end of 2018. Over the next five years, the project is expected to create 200 to 250 full-time jobs in the region.

Quotes

“This is another strategic milestone for Tilray as we aim to build the world’s most trusted and admired medical cannabis brand. As governments around the world increase access to medical cannabis, and as Canada prepares to legalize and regulate cannabis for responsible adult consumption, this investment will enable us to serve the rapidly expanding global market for quality-controlled, rigorously tested medical cannabis products. The Enniskillen facility is strategically located with a strong workforce of qualified, skilled agricultural professionals, and we are excited to be expanding our production processes there.” – Brendan Kennedy, Tilray Chief Executive Officer

“Tilray’s decision to invest in a cultivation and production facility in Enniskillen is truly exciting, bringing quality jobs to the Sarnia-Lambton region in a rapidly expanding sector. It’s no surprise that Tilray chose Ontario, as our province has one of the most competitive corporate tax rates in North America, an abundance of highly-skilled workers, and an incredibly robust agricultural sector. The new production facility in Enniskillen shows that Ontario is competitive in this growing new sector. The Government of Ontario’s new Ontario Investment Office worked tirelessly with Tilray to secure this important project. We’re very pleased to welcome Tilray to our province, and look forward to continuing to work with them as their expansion moves forward.” – Brad Duguid, Ontario Minister of Economic Growth and Development

“I am pleased to welcome Tilray to Sarnia-Lambton. This new facility in the township of Enniskillen will create good jobs and growth for our community. It is an important step in diversifying our industry and will be a great help to Canadian patients.” – Marilyn Gladu, MP for Sarnia-Lambton

“I’m very excited to learn about Tilray’s investment plans in the Township of Enniskillen. This is truly a great news story for the local rural economy and will have a huge amount of impact on all us in Sarnia-Lambton with the potential creation of 250 jobs. I’m proud to welcome this news from Tilray as we work towards building a better Sarnia-Lambton.” – Bob Bailey, MPP for Sarnia-Lambton

“As the Mayor of the Township of Enniskillen, I’m very happy to work with Tilray to take the steps needed to make this endeavor a reality in the community. This diversification will help our community grow and prosper in the ever changing and challenging economy.” – Kevin Marriott, Mayor of the Township of Enniskillen

“We embrace all opportunities for growth and development. From pepper plants to cannabis, our region is known for its agricultural capability. This investment will allow our community the chance to be part of a growing industry and allows the region to showcase its agricultural capability.” – Jack Greydanus, Owner of the Enniskillen Pepper Company.

About Tilray

Tilray is a global leader in medical cannabis research and production dedicated to advancing the science, safety, and efficacy of cannabinoids for a diverse range of conditions. The company operates one of the largest and most sophisticated federally licensed, GMP-certified medical cannabis cultivation facilities in the world, offering a range of products to patients, physicians, pharmacies, governments, hospitals and researchers in Australia, Canada, the European Union, New Zealand and Latin America.
papapuff
 
Posts: 10465
Joined: Thu May 29, 2008 11:19 pm
Location: Victoria BC

PreviousNext

Return to News

  • Advertisement
cron